Mohamed Abou-el-Enein, MD, PhD, MSPH, has joined the Keck School of Medicine as the inaugural Executive Director of the Joint USC/CHLA Cell Therapy Program. He began his post Jan. 4. Abou-el-Enein will also serve as Medical Director of the new cGMP facility for cell and gene therapy that is under construction in the Norris Research…Continue Reading Mohamed Abou-el-Enein named Executive Director of USC/CHLA Cell Therapy Program
